Direktorat Registrasi ObatValid

HUMALOG MIX50 KWIKPEN

BPOM Number: DKI2488803243B1
Approved: 15 October 2025
Expiry: 9 October 2030
Form: SUSPENSI INJEKSI

About This Registration

HUMALOG MIX50 KWIKPEN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2488803243B1. Its current registration status is Valid, with the licence valid until 9 October 2030. The product is registered to WIGO HEALTH INDONESIA - INDONESIA. BPOM first approved this registration in October 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 5 PREFILLED PEN @ 3 ML
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

WIGO HEALTH INDONESIA - INDONESIA
KAB. SEMARANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

WIGO HEALTH INDONESIA - INDONESIA
KAB. SEMARANG
primary
View profile →

Ingredients (1)

INSULIN LISPRO

Market Intelligence

Owner Portfolio: WIGO HEALTH INDONESIA - INDONESIA holds 54 BPOM registrations
Manufacturer Scale: WIGO HEALTH INDONESIA - INDONESIA produces 54 registered products
Registration Age: Registered for 11 months

FDA Cross-Reference

via openFDA

Generic Name: INSULIN LISPRO
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?